Medicine guide
COVID-19 Vaccine (inactivated, adjuvanted) Valneva
·
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- COVID-19 vaccine (inactivated, adjuvanted, adsorbed)
- Made by
- Valneva Austria GmbH
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- COVID-19 Vaccine (inactivated, adjuvanted) Valneva is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 to 50 years of age. The use of this vaccine should be in accordance with official recommendations.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | Valneva Austria GmbH |
|---|---|
| Active substance | COVID-19 vaccine (inactivated, adjuvanted, adsorbed) |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Classification | J07BX03 · Antibiotics, antivirals and antifungals taken into the body |
| Additional monitoring ▼ | Yes — under additional monitoring (black triangle). Report suspected side effects. |
| Authorised on | 2022-06-24 |
| Last updated by the regulator | 2023-12-01 |
| EMA product number | EMEA/H/C/006019 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).